Celebrate King's Day with TNW 🎟 Use code GEZELLIG40 on your Business, Investor and Startup passes today! This offer ends on April 29 →

This article was published on May 2, 2018

Controversial CEO and ‘biohacker’ Aaron Traywick found dead at 28


Controversial CEO and ‘biohacker’ Aaron Traywick found dead at 28 Image by: News2Share

The CEO of Ascendence Biomedical, Aaron Traywick, was found dead in a flotation therapy tank in Washington D.C. earlier this week.

What happened: Authorities from the Washington D.C. Metropolitan Police Department are still investigating and haven’t released much information yet, other than to say there’s currently no suspicion of foul-play. The cause of death has not been determined/released as of the time of this writing.

Traywick, who was only 28, was found dead after reportedly losing touch with colleagues. Andreas Sturmer, who worked with Traywick, told Vice News that he hadn’t heard from him recently, “We all lost touch with him. It was radio silence. It was more than four weeks ago.”

For context: Ascendence Biomedical is a controversial company, perhaps best known for its employees’ willingness to forgo scientific method and medical protocol by experimenting on themselves.

Traywick, who had no medical background, once injected himself with an experimental herpes treatment on stage during a conference. Another employee of the company self-tested an HIV treatment in a similar fashion.

No matter your thoughts on Traywick’s conduct, ethics, or his company, he was a unique person and a spirited member of the biomedical community. Tristan Roberts, another colleague of Traywick’s, told Vice News:

While many in the biohacking scene disagreed with his methods, none of them doubted his intentions. He sought nothing short of a revolution in biomedicine; the democratization of science and the opening of the flood gates for global healing.

The Next Web’s 2018 conference is just a few weeks away, and it’ll be ??. Find out all about our tracks here.

Get the TNW newsletter

Get the most important tech news in your inbox each week.